SCHEMBL8941153

SCHEMBL8941153

CC(C)c1cc(C(C)C)c(OS(=O)(=O)CC(=O)N(Cc2ccc(CS)cc2)C(C)C)c(C(C)C)c1

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SOAT2 O75908 1/20 0.38
MYC P01106 1/20 0.38
SOAT1 P35610 1/20 0.38
MAP2K3 P46734 1/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
RXRA P19793 2/20 0.33
FABP3 P05413 1/20 0.33
FABP4 P15090 1/20 0.33
FABP5 Q01469 1/20 0.33
BMP1 P13497 1/20 0.31
LMNA P02545 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9059390 0.90 SOAT2 (0.36) SOAT2MYCSOAT1MAP2K3KMT2A
SCHEMBL8941259 0.79 SOAT2 (0.42) SOAT2MYCSOAT1MAP2K3KMT2A
SCHEMBL8941282 0.73 SOAT2 (0.46) SOAT2MYCSOAT1MAP2K3RXRA
SCHEMBL8941381 0.67 SOAT1 (0.55) SOAT2MYCSOAT1MAP2K3KMT2A
SCHEMBL8941260 0.66 SOAT2 (0.48) SOAT2MYCSOAT1MAP2K3KMT2A
SCHEMBL8941150 0.65 FABP3 (0.36) KMT2AMEN1FABP3FABP4FABP5
SCHEMBL9059388 0.64 ENPP3 (0.39) KMT2AMEN1FABP3FABP4FABP5
SCHEMBL14015388 0.64 FABP4 (0.58) SOAT2MYCSOAT1MAP2K3FABP3
SCHEMBL28812298 0.63 SOAT2 (0.43) SOAT2MYCSOAT1MAP2K3RXRA
SCHEMBL2456678 0.62 FABP4 (0.50) SOAT2MYCSOAT1MAP2K3FABP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996019444-A1 SULFONATE ACAT INHIBITORS WARNER-LAMBERT COMPANY (US) 1996-06-27 WO disclosed
US-5510379-A USEFUL FOR TREATING HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-04-23 US disclosed